GoingToMeet

The incidence of asthma and COPD has risen significantly in recent years but drug developers have responded accordingly and progress in treatment is being made all the time. SMi’s sixth annual Asthma & COPD conference will provide attendees with an unrivalled forum for discussion and debate with access to a selection of expert speakers. As always, the primary focus will be on helping pharmaceutical companies and CRO’s to explore the key issues affecting their drug development processes while providing exceptional networking opportunities in a comfortable environment.

Why should you attend this event?

Explore the use of ex vivo human tissue and cell models
Discuss the potential effects of European legislation
Devise new approaches to analytical testing of Asthma and COPD products
Hear about novel endpoints in COPD clinical trials
Network with industry associates and share experiences

Hear keynote addresses from:

Peter Barnes, Professor of Thoracic Medicine, Imperial College London
Matthew Catley, Senior Research Scientist, UCB Celltech

Our expert speaker line-up also includes:

Phillip Monk, Chief Scientific Officer, Synairgen
Chris Compton, Vice President, Respiratory Franchise, Novartis
Julien Giovannini, Team Manager, Early Development, AstraZeneca